Citation Impact
Citing Papers
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
2008
Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets
2004 Standout
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
2009
Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
2008
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
2009
Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
2006
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Interferons and Apoptosis
2003
HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
2011
Hallmarks of Cancer: The Next Generation
2011 Standout
Sparse canonical methods for biological data integration: application to a cross-platform study
2009
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
1999
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Emerging insights into the molecular and cellular basis of glioblastoma
2012
Formation of the Androgen Receptor Transcription Complex
2002
Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability
2008
Pancreatic cancer
2004 Standout
IDH1andIDH2Mutations in Gliomas
2009 Standout
Effects of poly(l-lysine)-modified Fe3O4 nanoparticles on endogenous reactive oxygen species in cancer stem cells
2012
Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR
2002 Standout
Polymeric Structure and Host Toll-like Receptor 4 Dictate Immunogenicity of NY-ESO-1 Antigen in Vivo
2011
Genetic Pathways to Primary and Secondary Glioblastoma
2007
A Role for Fibrillar Collagen Deposition and the Collagen Internalization Receptor Endo180 in Glioma Invasion
2010
TGFβ signalling in context
2012 Standout
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
2009 Standout
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
2010
A new mathematical model for relative quantification in real-time RT-PCR
2001 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma
2012
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Antiangiogenic therapy in malignant gliomas
2008
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Integrating single-cell transcriptomic data across different conditions, technologies, and species
2018 Standout
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Validation of a quantitative method for real time PCR kinetics
2002
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Autocrine TGF-β Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors
2009
Mechanisms of Disease: genetic predictors of response to treatment in brain tumors
2007
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
2012
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
2009
Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
2012
Clinical application of IL6 in cancer therapy
1992
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
Novel approaches in the therapy of metastatic renal cell carcinoma
2005
Malignant Gliomas in Adults
2008 Standout
Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression
2015
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
2009
Inhibiting kinases in malignant gliomas
2007
EMT: 2016
2016 Standout
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Primary brain tumours in adults
2012 Standout
Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: A possible event in tumor regression
1998
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
1997
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
A restricted cell population propagates glioblastoma growth after chemotherapy
2012 StandoutNature
Diagnosis and Treatment of High-Grade Astrocytoma
2007
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays
2000 Standout
Modulation of carbonic anhydrase activity and its applications in therapy
2004
Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production
2003 StandoutNobel
Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas
1994
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
1999 Standout
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Bevacizumab and chemotherapy for recurrent glioblastoma
2009
Molecular Predictors in Glioblastoma
2008
Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor
1997
Angiogenesis as a Therapeutic Target in Malignant Gliomas
2009
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
2003
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
2000
Blockade of the epidermal growth factor receptor signaling inhibits angiogenesis leading to regression of human renal cell carcinoma growing orthotopically in nude mice.
2002
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline
2010 StandoutNobel
The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway
1998
Gene-based vaccines and immunotherapeutics
2004
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
2005
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.
2006
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Cho-Lea Tso being referenced
Primary Glioblastomas Express Mesenchymal Stem-Like Properties
2006
Distinct Transcription Profiles of Primary and Secondary Glioblastoma Subgroups
2006
Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
2009
A Pilot Trial of Tumor Lysate-Loaded Dendritic Cells for the Treatment of Metastatic Renal Cell Carcinoma
2003
Natural Immune Reactivity-Associated Therapeutic Response in Patients with Metastatic Renal Cell Carcinoma Receiving Tumor-Infiltrating Lymphocytes and Interleukin-2-Based Therapy
1996
Prostate Tissue Specificity of the Prostate-Specific Antigen Promoter Isolated from a Patient with Prostate Cancer
1995
Phase I Trial of Antigen-Specific Gene Therapy Using a Recombinant Vaccinia Virus Encoding MUC-1 and IL-2 in MUC-1-Positive Patients With Advanced Prostate Cancer
2004
Interleukin-6 and renal cell cancer: Production, regulation, and growth effects
1992
In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer
1994
Sensitization of Renal Carcinoma to Radiation Using Alpha Interferon (IFNA) Gene Transfection
1997
Relationship between Survival and Edema in Malignant Gliomas: Role of Vascular Endothelial Growth Factor and Neuronal Pentraxin 2
2007
Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
2003
Quantitative Polymerase Chain Reaction Does not Improve Preoperative Prostate Cancer Staging: A Clinicopathological Molecular Analysis of 121 Patients
1996